Market Rally and Fed Aftermath, Starbucks Surges, Gains for Lilly and Novo Nordisk 11/2/23

Jim Cramer and Sara Eisen discussed what to make of Wednesday's Fed decision on interest rates and comments from the central bank's chair Jerome Powell. This as bond yields fall, the Dow and S&P 500 aim for a fourth straight day of gains and the Nasdaq goes for a five-day win streak. Starbucks shares surged on better-than-expected Q4 results. Shares of anti-obesity drugmakers also saw gains: "Mounjaro" manufacturer Eli Lilly and Novo Nordisk -- the home of "Ozempic" and "Wegovy" -- posted quarterly beats. Also in focus: More earnings winners and losers, plus what to expect from Apple's after-the-bell results. Squawk on the Street Disclaimer